2014
DOI: 10.1016/j.surg.2013.12.037
|View full text |Cite
|
Sign up to set email alerts
|

Blockage of CXCR2 suppresses tumor growth of intrahepatic cholangiocellular carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
27
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 29 publications
(31 citation statements)
references
References 36 publications
1
27
0
Order By: Relevance
“…3b). These chemokines are reportedly key cytokines in the pathogenesis of CCA and its proliferative effect [20][21][22]. These data suggested the critical role of cholangiocyte senescence and the subsequent secretion of SASP components in the progression of biliary tract cancers associated with PBM and intrahepatic cholelithiasis.…”
Section: Discussionmentioning
confidence: 97%
“…3b). These chemokines are reportedly key cytokines in the pathogenesis of CCA and its proliferative effect [20][21][22]. These data suggested the critical role of cholangiocyte senescence and the subsequent secretion of SASP components in the progression of biliary tract cancers associated with PBM and intrahepatic cholelithiasis.…”
Section: Discussionmentioning
confidence: 97%
“…). Interestingly, a previous report has demonstrated that blocking of CXC chemokine receptor 2, receptors for chemokines including CXCL8, CXCL1, CXCL2, and CXCL3 suppressed the development of cholangiocarcinoma .…”
Section: Discussionmentioning
confidence: 99%
“…Finally, a recently published study by Sueoka et al investigated the role of CXCR2 in promoting the development and growth of cholangiocarcinoma in vitro and in vivo. The authors showed that (i) blockage of CXCR2 using a knockdown strategy or a CXCR2 antagonist suppresses the growth of cholangiocarcinoma, (ii) CXCR2 is up-regulated in cholangiocarcinoma compared to adjacent liver tissue in human tissue resections, (iii) CXCR2 has a prognostic value in patients with intrahepatic cholangiocarcinoma (patients with high CXCR2 expression levels showed a poorer prognosis than patients with low CXCR2 levels), all suggesting that blocking CXCR2 may be a promising therapeutic approach for cholangiocarcinoma [36].…”
Section: Cholangiocarcinomamentioning
confidence: 99%